Related Experiment Video

Updated: Jun 20, 2026

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

[Pathophysiology of neuronal injury in bacterial meningitis and experimental adjunctive therapeutic approaches]

T Böttcher1

  • 1Dietrich-Bonhoeffer-Klinikum, Klinik für Neurologie, S.-Allende-Strasse 30, Neubrandenburg. toboettcher@gmx.de

Fortschritte Der Neurologie-Psychiatrie
|August 18, 2009
PubMed

Insights

Bacterial meningitis treatment faces challenges with high mortality. Non-lytic antibiotics may offer neuroprotection by reducing inflammation, unlike current therapies.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pharmacology

Context:

  • Bacterial meningitis remains a leading cause of death and neurological disability.
  • Current intensive care and beta-lactam antibiotic therapy show limited success in reducing mortality.
  • Beta-lactam antibiotics cause bacterial lysis, releasing inflammatory components and exacerbating meningitis.

Purpose:

  • To explore alternative antibiotic strategies for bacterial meningitis.
  • To investigate the neuroprotective potential of non-lytic antibiotics.

Summary:

  • Bacterial meningitis involves multiple detrimental factors, including inflammation triggered by antibiotic lysis of bacteria.
  • Beta-lactam antibiotics, while effective against bacteria, worsen meningeal inflammation due to bacterial cell wall release.
  • Non-bacteriolytic, protein-synthesis inhibiting antibiotics demonstrated neuroprotection in experimental pneumococcal meningitis by reducing inflammation.

Impact:

  • Suggests a novel therapeutic approach for bacterial meningitis, focusing on reducing inflammation rather than solely bacterial killing.
  • Highlights the potential of protein-synthesis inhibiting antibiotics as an adjunctive therapy to improve outcomes in bacterial meningitis.
  • Offers a promising strategy for neuroprotection in bacterial meningitis by mitigating the inflammatory cascade.

More Related Videos

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...